COFCO Biotechnology Co., Ltd. (SHE:000930)
China · Delayed Price · Currency is CNY 5.15
+0.20 (4.04%)
Sep 4, 2026, 3:04 PM CST
COFCO Biotechnology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,817 | 2,488 | 1,909 | 1,481 | 1,017 | 1,116 |
Trading Asset Securities | - | - | - | - | 3.82 | 1.86 |
Cash & Short-Term Investments | 1,817 | 2,488 | 1,909 | 1,481 | 1,020 | 1,118 |
Cash Growth | 1.15% | 30.30% | 28.91% | 45.14% | -8.71% | 68.77% |
Accounts Receivable | 1,326 | 951.94 | 1,277 | 1,124 | 1,370 | 1,189 |
Other Receivables | 154.44 | 133.95 | 114.69 | 196 | 168.42 | 293.76 |
Receivables | 1,480 | 1,086 | 1,392 | 1,320 | 1,538 | 1,483 |
Inventory | 2,780 | 1,886 | 2,770 | 2,534 | 3,763 | 4,052 |
Other Current Assets | 918.81 | 660.59 | 739.34 | 700.37 | 1,349 | 982.02 |
Total Current Assets | 6,997 | 6,120 | 6,810 | 6,035 | 7,671 | 7,635 |
Property, Plant & Equipment | 8,752 | 8,722 | 8,590 | 8,632 | 8,611 | 8,515 |
Long-Term Investments | 437.57 | 446.39 | 548.06 | 535.39 | 536.93 | 512.12 |
Goodwill | 366.04 | 366.04 | 366.04 | 366.04 | 366.04 | 366.04 |
Other Intangible Assets | 617.96 | 624.56 | 601.01 | 601.15 | 609.08 | 628.96 |
Long-Term Deferred Tax Assets | 335.75 | 328.03 | 280.07 | 265.01 | 193.49 | 202.99 |
Long-Term Deferred Charges | 47.16 | 49.97 | 40.99 | 41.94 | 31.31 | 25.23 |
Other Long-Term Assets | 107.62 | 110.35 | 93.07 | 80.94 | 110.52 | 171.76 |
Total Assets | 17,661 | 16,768 | 17,329 | 16,558 | 18,129 | 18,057 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 667.77 | 537.45 | 728.36 | 766.49 | 919.59 | 920.25 |
Accrued Expenses | 113.37 | 219.87 | 250.81 | 262.96 | 360.15 | 418.44 |
Short-Term Debt | 2,505 | 1,864 | 4,000 | 3,217 | 2,874 | 2,764 |
Current Portion of Long-Term Debt | 60.03 | 23.87 | 61.41 | 44.93 | 42.67 | 86.61 |
Current Portion of Leases | - | 18.75 | 17.95 | 19.18 | 12.08 | 20.81 |
Current Income Taxes Payable | 77.51 | 43.35 | 46.57 | 47.59 | 61.58 | 35 |
Current Unearned Revenue | 356.64 | 187.85 | 223.88 | 266.39 | 278.73 | 328.64 |
Other Current Liabilities | 2,201 | 2,124 | 507.86 | 517.47 | 612.33 | 1,015 |
Total Current Liabilities | 5,981 | 5,019 | 5,837 | 5,142 | 5,162 | 5,589 |
Long-Term Debt | 509.02 | 367.8 | 165.1 | 165.65 | 191.28 | 406.4 |
Long-Term Leases | 160.36 | 158.32 | 177.11 | 196.64 | 105.63 | 117.3 |
Long-Term Unearned Revenue | 98.35 | 100.14 | 99.73 | 70.01 | 72.6 | 113.79 |
Long-Term Deferred Tax Liabilities | 44.64 | 44.7 | 66.39 | 89 | 60.89 | 32.07 |
Other Long-Term Liabilities | 61.9 | 63 | 67.8 | 41.19 | 27.33 | 43.32 |
Total Liabilities | 6,856 | 5,753 | 6,413 | 5,704 | 5,619 | 6,302 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,856 | 1,856 | 1,860 | 1,865 | 1,865 | 1,866 |
Additional Paid-In Capital | 6,088 | 6,088 | 6,102 | 6,126 | 6,135 | 6,131 |
Retained Earnings | 1,786 | 1,908 | 1,810 | 1,784 | 3,449 | 2,847 |
Treasury Stock | - | - | -13.2 | -33.31 | -43.03 | -66.89 |
Comprehensive Income & Other | 674.06 | 759.46 | 760.14 | 709.5 | 692.84 | 616.89 |
Total Common Equity | 10,405 | 10,611 | 10,518 | 10,452 | 12,098 | 11,394 |
Minority Interest | 400.26 | 403.39 | 398.22 | 401.96 | 411.53 | 361.42 |
Shareholders' Equity | 10,805 | 11,015 | 10,916 | 10,854 | 12,510 | 11,755 |
Total Liabilities & Equity | 17,661 | 16,768 | 17,329 | 16,558 | 18,129 | 18,057 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 3,235 | 2,433 | 4,421 | 3,643 | 3,226 | 3,395 |
Net Cash (Debt) | -1,418 | 54.96 | -2,512 | -2,162 | -2,206 | -2,278 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.77 | 0.03 | -1.35 | -1.17 | -1.19 | -1.23 |
Filing Date Shares Outstanding | 1,856 | 1,856 | 1,860 | 1,865 | 1,865 | 1,866 |
Total Common Shares Outstanding | 1,856 | 1,856 | 1,860 | 1,865 | 1,865 | 1,866 |
Working Capital | 1,015 | 1,101 | 973.45 | 893.51 | 2,509 | 2,046 |
Book Value Per Share | 5.60 | 5.72 | 5.66 | 5.60 | 6.49 | 6.11 |
Tangible Book Value | 9,421 | 9,621 | 9,551 | 9,484 | 11,123 | 10,399 |
Tangible Book Value Per Share | 5.07 | 5.18 | 5.14 | 5.09 | 5.96 | 5.57 |
Buildings | - | 4,563 | 4,530 | 4,447 | 4,678 | 4,534 |
Machinery | - | 9,917 | 9,785 | 9,495 | 9,830 | 9,025 |
Construction In Progress | - | 752.6 | 350.05 | 312.19 | 84.39 | 720.9 |